2 members of Congress have disclosed 3 trades in ImmunityBio, Inc. (IBRX) since 2023: 2 purchases worth about $16.00K and 1 sale worth about $8.00K. The most active was Lisa C. McClain, with 2 trades. The latest trade was made on Sep 30, 2026.
IBRX’s price and SPY’s, both as the change since the start of the range. A green triangle marks a day members bought IBRX, a red one a day they sold; hover for who and how much.
| # | Member | Trades | Buys | Sells | Bought (est.) | Sold (est.) | Net | Buys vs SPY | First Traded | Last Traded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Lisa C. McClainR-MI | 2 | 2 | 0 | $16.00K | $0.00 | +$16.00K | -9.7% | Sep 28, 2026 | Sep 30, 2026 |
| 2 | Daniel S. GoldmanD-NY | 1 | 0 | 1 | $0.00 | $8.00K | -$8.00K | – | Mar 6, 2023 | Mar 6, 2023 |
| Owner | Type | Filing | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Lisa C. McClainR-MI | IBRXImmunityBio, Inc. - Common Stock | Spouse | Buy | $1K–$15K | Sep 30, 2026 | Oct 12, 2026 | 12d | -15.8% | -14.4% | |
| Lisa C. McClainR-MI | IBRXImmunityBio, Inc. - Common Stock | Spouse | Buy | $1K–$15K | Sep 28, 2026 | Oct 12, 2026 | 14d | -6.7% | -4.9% | |
| Daniel S. GoldmanD-NY | IBRXImmunityBio, Inc. | Self | Sell | $1K–$15K | Mar 6, 2023 | Apr 17, 2023 | 42d | +351.7% | +265.7% |
Tip. Hover a row for the filing’s full asset text and comments; the PDF link opens the report itself.
2 members of Congress have disclosed 3 trades in ImmunityBio, Inc. (IBRX) since 2023: 2 purchases worth about $16.00K and 1 sale worth about $8.00K. The most active was Lisa C. McClain, with 2 trades. The latest trade was made on Sep 30, 2026. Most active: Lisa C. McClain (2), Daniel S. Goldman (1).
Since 2023 they have disclosed 2 purchases and 1 sale; by the midpoints of the disclosed ranges, about $16.00K bought and $8.00K sold, a net purchase of $8.00K.
Members of Congress report each trade over $1,000 within 45 days under the STOCK Act, with the amount as a range. The chart marks the days members traded IBRX on its price, against the S&P 500 over the same days.
Members of Congress disclose trades as dollar ranges, up to 45 days after the trade and sometimes later. Volumes use the midpoints of those ranges and are estimates; portfolio figures are a model built from the disclosed trades, not the members’ actual accounts. Not investment advice.